Lion Point Capital, LP’s Sarepta Therapeutics Inc Position
Does Lion Point Capital, LP own Sarepta Therapeutics Inc (SRPT)? Yes — 28.5K shares worth $620,160 (+3.71% of its 13F portfolio) as of Q1 2026.
Position Value
$620,160
Q1 2026
Shares
28.5K
% of Portfolio
+3.71%
Quarters Held
2
currently held
Position History SRPT
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lion Point Capital, LP’s full portfolio or all institutional holders of SRPT.